News

Emerging research suggests that cannabidiol (CBD) extract may offer meaningful benefits for children and adolescents with autism spectrum disorder (ASD), according to a meta-analysis presented at the European Psychiatric Association (EPA) Congress 2025.

Mass General Brigham researchers, in collaboration with Boston Children’s Hospital and Dana-Farber/Boston Children’s Cancer and Blood Disorders Center, have unveiled a promising advance in pediatric brain tumor care:

Researchers from the University of Bonn and DZNE uncover the role of brain inflammation in spastic paraplegia type 15, offering new therapeutic possibilities.

In a groundbreaking discovery, researchers at the Mayo Clinic have identified specific brain cell changes that may explain the involuntary tics characteristic of Tourette syndrome.

New research uncovers important genetic clues that may help predict treatment resistance in focal epilepsy.

A new study from the University of Michigan is breaking fresh ground by using artificial intelligence to better support neurodivergent children in physical activity programs.

A major step forward in mitochondrial medicine has been announced by researchers at the University of Gothenburg, with the potential to pave the way for the first treatment targeting diseases caused by genetic defects in cellular energy production.

Mayo Clinic researchers pioneer AI-driven, patient-centered therapy